Literature DB >> 16358228

Urinary sediment features in proliferative and non-proliferative glomerular diseases.

Giovanni B Fogazzi1, Lucia Saglimbeni, Giovanni Banfi, Mariadele Cantú, Gabriella Moroni, Giuseppe Garigali, Bruno M Cesana.   

Abstract

BACKGROUND: The studies on urine sediment particles in patients with glomerular diseases (GD) are few and have focused only on single urine particles. In this study, we investigated the prevalence and number of 12 urine sediment particles in two groups of patients, one with proliferative GD, and the other with non-proliferative GD.
METHODS: The urine sediment of 100 consecutive patients, with a renal biopsy-proven proliferative or non-proliferative GD and marked cylindruria, were examined a few hours before renal biopsy according to a standardized method. The urine particles investigated were erythrocytes, leukocytes, renal tubular cells, lipids and hyaline, hyaline-granular, granular, waxy, erythrocytic, leukocytic, epithelial and fatty casts.
RESULTS: Patients with proliferative GD (n=52) had both a significantly higher prevalence of microscopic hematuria, leukocyturia, tubular epithelial cells, erythrocytic casts, epithelial casts, and significantly higher amounts of erythrocytes,leukocytes, tubular epithelial cells/20 high power field (HPF), erythrocytic and epithelial casts. On the other hand, patients with non-proliferative GD (n=48) had significantly higher numbers of fatty casts. In proliferative GD, leukocyturia was associated with intracapillary and extracapillary proliferation, crescents and fibrinoid necrosis at renal biopsy. At discriminant analysis, the two types of GD could be identified with 80.8% sensitivity and 79.2% specificity. By multiple logistic regression analysis, patients with erythrocytes, leukocytes and erythrocytic casts in the urine had an odds ratio (OR) of 9.91 (95% confidence interval (95% CI): 1.01-97.51), 7.85 (95% CI: 2.77-22.20), and 4.33 (95% CI: 1.41-13.31), respectively, of having proliferative GD.
CONCLUSIONS: Our examination of the urine sediment shows that proliferative GD and non-proliferative GD differ in many respects.

Entities:  

Mesh:

Year:  2005        PMID: 16358228

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  7 in total

1.  Atypical case of AL amyloidosis with urinary erythrocyte casts.

Authors:  Orfeas Liangos; Maike Buettner-Herold; Markus Ketteler; Nicolaos E Madias
Journal:  Clin Nephrol Case Stud       Date:  2015-09-23

2.  Proliferative, necrotizing and crescentic immune complex-mediated glomerulonephritis in a cat.

Authors:  Carolyn Gross; Rachel E Cianciolo; George E Lees; Cathy A Brown; Jonathan D Foster
Journal:  JFMS Open Rep       Date:  2015-09-03

3.  Performance of the Automated Urinalysis in Diagnosis of Proliferative Glomerulonephritis.

Authors:  Ragnar Palsson; Anand Srivastava; Sushrut S Waikar
Journal:  Kidney Int Rep       Date:  2019-02-12

4.  Survey on reporting of epithelial cells in urine sediment as part of external quality assessment programs in Brazilian laboratories.

Authors:  José A T Poloni; Adriana de Oliveira Vieira; Caroline R M Dos Santos; Ana-Maria Simundic; Liane N Rotta
Journal:  Biochem Med (Zagreb)       Date:  2021-06-15       Impact factor: 2.313

5.  Urine annexin A1 as an index for glomerular injury in patients.

Authors:  Shuk-Man Ka; Pei-Yi Tsai; Tai-Kuang Chao; Shun-Min Yang; Yi-Jen Hung; Jin-Shuen Chen; Hao-Ai Shui; Ann Chen
Journal:  Dis Markers       Date:  2014-01-20       Impact factor: 3.434

6.  Urinary cytology: a potential tool for differential diagnosis of acute kidney injury in patients with nephrotic syndrome.

Authors:  Caroline Vilas Boas de Melo; Maria Brandão Tavares; Paula Neves Fernandes; Carlos Alberto Dos Santos Silva; Ricardo David Couto; Marília Bahiense Oliveira; Washington L C Dos-Santos
Journal:  BMC Res Notes       Date:  2020-08-27

Review 7.  Prediction of prognosis and renal outcome in lupus nephritis.

Authors:  Ioannis Parodis; Farah Tamirou; Frédéric A Houssiau
Journal:  Lupus Sci Med       Date:  2020-02-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.